S.Amdt. 469Senate111th Congress (2009-2011)2nd degree
S.Amdt. 469
Sponsored by
Sen. Mike Crapo (R-ID)
Submitted February 5, 2009
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
February 5, 2009
Text
Submitted
SA 469. Mr. CRAPO submitted an amendment intended to be proposed to amendment SA 98 proposed by Mr. Inouye (for himself and Mr. Baucus) to the bill H.R. 1, making supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009, and for other purposes; which was ordered to lie on the table; as follows: On page 735, after line 7, add the following: SEC. 5006. MEDICAID REBATES FOR PHYSICIAN ADMINISTERED DRUGS. (a) Extension for Implementation of Requirement for Hospitals to Submit Utilization Data.--Section 1927(a)(7) of the Social Security Act (42 U.S.C. 1396r-8(a)(7)) is amended-- (1) in subparagraph (A), by inserting ``in non-hospital settings and on or after November 1, 2009, in hospitals'' after ``January 1, 2006,''; (2) in subparagraph (B)(ii), by inserting ``in non-hospital settings and on or after November 1, 2009, in hospitals'' after ``January 1, 2008,''; and (3) in subparagraph (C), by inserting ``(November 1, 2009, in the case of hospital information),'' after ``January 1, 2007,''. (b) Proportional Rebates for Dual Eligible Claims.--Section 1927(a)(7) of the Social Security Act (42 U.S.C. Sec. 1396r- 8(a)(7)) is amended by adding at the end the following new subparagraph: ``(E) Temporary adjustment to rebate calculation for dual eligible claims.--Only with respect to claims for rebates submitted by States to manufacturers during the 2-year period that begins on the date of enactment of this subparagraph, for purposes of calculating the amount of rebate under subsection (c) for a rebate period for a covered outpatient drug for which payment is made under a State plan or waiver under this title and under part B of title XVIII, the total number of units reported by the State of each dosage form and strength of each such drug paid for under the State plan or waiver under this title during such rebate period is deemed to be equal to the product of-- ``(i) such total number of units of such drug for which payment is made under the State plan or waiver under this title and under part B of title XVIII; and ``(ii) the proportion (expressed as a percentage) that the amount the State paid for each dosage form and strength of such drug under the State plan or waiver under this title during such rebate period bears to the amount that the State would have paid for each dosage form and strength of such drug under the State plan or waiver under this title during such rebate period if the State were the sole payer for such dosage form and strength of such drug.''. ______